Autoscribe Informatics exhibiting at Pittcon 2012
News Mar 11, 2012
Autoscribe Informatics Inc. will be showcasing its laboratory and business management solutions at Booth 1758 during Pittcon 2012, being held March 12 -15 in Orlando, Florida.
As the world's premier Conference and Exposition on laboratory science, Pittcon is the perfect event for promoting Autoscribe’s extensive range of LIMS and tracking solutions and presenting new solutions as part of its continuing success within many market sectors such as water, environmental, food and health sciences in the US and Canada.
Pittcon 2012 will see the debut of Autoscribe Informatics Inc. - a new and wholly owned US subsidiary of Autoscribe Ltd, located in Falmouth, MA. Autoscribe Informatics Inc. began operations in January this year thus emphasizing Autoscribe’s strong commitment to the customer base within North America.
With over 20 years of delivering long term configurable and scalable solutions, Autoscribe has expert knowledge in the development and supply of software solutions that are tailored to individual customer requirements without the need for custom coding. The unique features and benefits of Autoscribe’s solutions have positioned it as a worldwide leader in genuinely configurable software solutions serving a wide variety of industries and market sectors.
Single-stranded Origami Technology Drives Drug Delivery Systems and Pharmaceutical Nanofactories ForwardNews
First nanotechnological approach enables the design and replication of complex single-stranded DNA and RNA origami with potential for drug delivery and nanofabrication.READ MORE
Leibniz Supercomputing Centre Introduces Plans for its Next-generation SuperMUC MachineNews
Leadership at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences and Humanities announced today that they have signed a contract with Intel and Lenovo to build SuperMUC-NG, the next generation of the centre's leading-edge supercomputers.READ MORE
New Computational Strategies Could Help Peptide Therapeutics DevelopmentNews
New computational strategies reported this week might help realize the promise of peptide-based drugs. Peptides are similar to protein molecules, but differ in their smaller size, structure and functions.READ MORE